Stock listing
KTTA Stock Price, News, Filings & Events — Pasithea Therapeutics Corp.
Selected listing: KTTA · BOATS · USD · US
This page tracks Pasithea Therapeutics Corp.'s KTTA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KTTA:BOATS. KTTA:BOATS is the stock-level entry point for investors researching Pasithea Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. The company has a market capitalization of approximately $15.2 million. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.

- Ticker
- KTTA:BOATS
- Asset type
- Stock
- Market cap
- $17.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Pasithea Therapeutics Corp. KTTA:BOATS stock context
This page tracks Pasithea Therapeutics Corp.'s KTTA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KTTA:BOATS. KTTA:BOATS is the stock-level entry point for investors researching Pasithea Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. The company has a market capitalization of approximately $15.2 million. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.
Latest news from Pasithea Therapeutics Corp.
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patient...
September 14, 2026
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
September 3, 2026
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
July 21, 2026
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
July 8, 2026
Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and ...
June 30, 2026
Research Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. investor report
Review AI stock analysis and investor report context for KTTA:BOATS.
Pasithea Therapeutics Corp. company profile
View the public company page for Pasithea Therapeutics Corp. on 6ix.
Pasithea Therapeutics Corp. news
Read company news and market updates connected to Pasithea Therapeutics Corp..
Pasithea Therapeutics Corp. investor events
Find investor webinars, events, and replay context for Pasithea Therapeutics Corp..